{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:40:56Z","timestamp":1760575256804,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"HOPE Cardiometabolic Research Team, Ilorin, Nigeria"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathophysiology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.pathophys.2019.06.001","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T02:22:58Z","timestamp":1559787778000},"page":"227-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Drospirenone-containing contraceptive exerts positive effects on cardiac uric acid and PAI-1 but not GSK-3: Improved safety profiles in contraception?"],"prefix":"10.1016","volume":"26","author":[{"given":"Oluwaseun A.","family":"Adeyanju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaniyi A.","family":"Soetan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence A.","family":"Olatunji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathophys.2019.06.001_bib0005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0010-7824(93)90034-5","article-title":"Effect of four combined oral contraceptives on blood pressure in the pill-free interval","volume":"47","author":"Nichols","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.pathophys.2019.06.001_bib0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jacc.2008.09.042","article-title":"Contraceptive hormone use and cardiovascular disease","volume":"53","author":"Shufelt","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0015","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ecl.2005.04.012","article-title":"Oral contraceptives and the management of hyperandrogenism\u2013polycystic ovary syndrome in adolescents","volume":"34","author":"Hillard","year":"2005","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0020","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/2047487312452966","article-title":"Oral contraceptive use in girls and alcohol consumption in boys are associated with increased blood pressure in late adolescence","volume":"20","author":"Le-Ha","year":"2013","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/13813455.2016.1151892","article-title":"Improvement of oral contraceptive-induced glucose dysregulation and dyslipidemia by valproic acid is independent of circulating corticosterone","volume":"122","author":"Olatunji","year":"2016","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0030","doi-asserted-by":"crossref","unstructured":"O.A. Adeyanju, O.S. Michael, A.O. Soladoye, L.A. Olatunji, Blockade of mineralocorticoid receptor ameliorates oral contraceptive-induced insulin resistance by suppressing elevated uric acid and glycogen synthase kinase-3 instead of circulating mineralocorticoid, Arch. Physiol. Biochem. https:\/\/doi.org\/10.1080\/13813455.2018.1509220 (Epub ahead of print).","DOI":"10.1080\/13813455.2018.1509220"},{"key":"10.1016\/j.pathophys.2019.06.001_bib0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mce.2003.10.030","article-title":"Drospirenone, a progestogen with antimineralocorticoid properties: a short review","volume":"217","author":"Oelkers","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0040","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.104.501502","article-title":"Antihypertensive effects of drospirenone with 17 beta-estradiol, a novel hormone treatment in postmenopausal woman with stage 1 hypertension","volume":"112","author":"White","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pathophys.2019.06.001_bib0045","first-page":"191","article-title":"Oral contraceptives and venous thromboembolism","volume":"35","author":"Manzoli","year":"2012","journal-title":"Drug Saf."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0050","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial dis-ease: a meta-analysis","volume":"90","author":"Baillargeon","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0055","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/abbi.1993.1342","article-title":"Mechanisms of multisite phosphorylation and inactivation of rabbit muscle glycogen synthase","volume":"304","author":"Zhang","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0060","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.2337\/diabetes.48.8.1662","article-title":"Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL\/6J mice","volume":"48","author":"Eldar-Finkelman","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.pathophys.2019.06.001_bib0065","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2337\/diabetes.49.2.263","article-title":"Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes","volume":"49","author":"Nikoulina","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.pathophys.2019.06.001_bib0070","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2174\/092986708783955455","article-title":"Fibrinolysis: the key to new pathogenic mechanisms","volume":"15","author":"Zorio","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0075","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2009-09-244962","article-title":"Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture","volume":"115","author":"Xu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pathophys.2019.06.001_bib0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF01061993","article-title":"Plasma concentration of endogenous tissue plasminogen activator and the occurrence of future cardiovascular events","volume":"1","author":"Ridker","year":"1994","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.pathophys.2019.06.001_bib0085","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1160\/TH08-08-0524","article-title":"The \u2018PAI-1 paradox\u2019 in vascular remodeling","volume":"100","author":"Diebold","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0090","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1001\/jama.1991.03470210076036","article-title":"Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration","volume":"266","author":"Facchini","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.pathophys.2019.06.001_bib0095","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.HYP.36.6.1072","article-title":"Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study","volume":"36","author":"Verdecchia","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.pathophys.2019.06.001_bib0100","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.fertnstert.2005.07.1311","article-title":"Efficacy of a new oral contraceptive containing drospirenone and ethinylestradiol in the long-term treatment of hirsutism","volume":"85","author":"Batukan","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0105","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.fertnstert.2009.10.016","article-title":"Comparison of effects of 3 mg drospirenone plus 20 mg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome","volume":"94","author":"Fruzzetti","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejogrb.2014.01.006","article-title":"Effects of a contraceptive containing drospirenone and ethinyl estradiol on blood pressure and autonomic tone: a prospective controlled clinical trial","volume":"175","author":"Nisenbaum","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.ATV.0000099786.99623.EF","article-title":"Adiponectin and metabolic syndrome","volume":"24","author":"Matsuzawa","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0120","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.HYP.0000188703.27002.14","article-title":"Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension","volume":"46","author":"Roberts","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pathophys.2019.06.001_bib0125","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1212\/01.wnl.0000277468.10236.f1","article-title":"Serum uric acid and brain ischemia in normal elderly adults","volume":"69","author":"Schretlen","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pathophys.2019.06.001_bib0130","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.thromres.2014.12.030","article-title":"Metabolic syndrome, platelet activation and the development of transient ischemic attack or thromboembolic stroke","volume":"135","author":"Van Rooy","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0135","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.amjcard.2006.11.066","article-title":"Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial)","volume":"99","author":"Nikolsky","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0140","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.amjcard.2014.04.045","article-title":"Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction","volume":"114","author":"Kurtul","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0145","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1055\/s-0038-1657653","article-title":"Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD)","volume":"78","author":"Meade","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0150","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1538-7836.2007.02528.x","article-title":"Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study","volume":"5","author":"Zakai","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0155","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ahj.2008.07.008","article-title":"Uncontrolled immune response in acute myocardial infarction: unraveling the thread","volume":"156","author":"Bodi","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MCA.0b013e328332ee15","article-title":"Low lymphocyte count in acute phase of ST-segment elevation myocardial infarction predicts long-term recurrent myocardial infarction","volume":"21","author":"N\u00fa\u00f1ez","year":"2010","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0165","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1161\/01.ATV.0000039169.47943.EE","article-title":"B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice","volume":"22","author":"Major","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0170","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1002\/art.25019","article-title":"Lymphopenia is a risk factor in the progression of carotid intima-media thickness in juvenile-onset systemic lupus erythematosus","volume":"60","author":"Huang","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2006.04.060","article-title":"An increased platelet\u2013leukocytes interaction at the culprit site of coronary artery occlusion in acute myocardial infarction: a pathogenic role for \u201cno-reflow\u201d phenomenon?","volume":"117","author":"Botto","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0180","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1161\/ATVBAHA.107.161471","article-title":"Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates","volume":"28","author":"Brambilla","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/0003319715574625","article-title":"Increased platelet to lymphocyte ratio is related to slow coronary flow","volume":"67","author":"Akboga","year":"2006","journal-title":"Angiology"},{"key":"10.1016\/j.pathophys.2019.06.001_bib0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/0003319715583186","article-title":"Association of platelet to lymphocyte ratio with inflammation and severity of coronary atherosclerosis in patients with stable coronary artery disease","volume":"67","author":"Akboga","year":"2010","journal-title":"Angiology"},{"key":"10.1016\/j.pathophys.2019.06.001_bib0195","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1371\/journal.pbio.0060037","article-title":"Genetic deficiency of glycogen synthase kinase-3\u03b2 corrects diabetes in mouse models of insulin resistance","volume":"6","author":"Tanabe","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0200","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cyto.2010.10.009","article-title":"Glycogen synthase kinase 3: a point of convergence for the host inflammatory response","volume":"53","author":"Wang","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.pathophys.2019.06.001_bib0205","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00125-006-0552-5","article-title":"Glycogen synthase kinase 3 inhibition improves insulin-stimulated glucose metabolism but not hypertension in high-fat-fed C57BL\/6J mice","volume":"50","author":"Rao","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.pathophys.2019.06.001_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2007.01.033","article-title":"The role of GSK3 in glucose homeostasis and the development of insulin resistance","volume":"77","author":"Lee","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0215","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrd1415","article-title":"GSK3 inhibitors: development and therapeutic potential","volume":"3","author":"Cohen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0220","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCRESAHA.116.303613","article-title":"The GSK-3 family as therapeutic target for myocardial diseases","volume":"116","author":"Lal","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0225","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1681\/ASN.2006050503","article-title":"Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action","volume":"17","author":"Eddy","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.pathophys.2019.06.001_bib0230","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/01.STR.31.1.26","article-title":"Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator\/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke","volume":"31","author":"Johansson","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.pathophys.2019.06.001_bib0235","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2337\/diabetes.53.2.336","article-title":"Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1","volume":"53","author":"Ma","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.pathophys.2019.06.001_bib0240","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.2174\/138945011797635803","article-title":"Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease","volume":"12","author":"Ploplis","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.pathophys.2019.06.001_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13813455.2016.1160935","article-title":"Activation of cardiac renin\u2013angiotensin system and plasminogen activator inhibitor-1 gene expressions in oral contraceptive-induced cardiometabolic disorder","volume":"123","author":"Olatunji","year":"2017","journal-title":"Arch. Physiol. Biochem."}],"container-title":["Pathophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928468019300422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928468019300422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:17:13Z","timestamp":1760530633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928468019300422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":49,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0928468019300422"],"URL":"https:\/\/doi.org\/10.1016\/j.pathophys.2019.06.001","relation":{},"ISSN":["0928-4680"],"issn-type":[{"type":"print","value":"0928-4680"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drospirenone-containing contraceptive exerts positive effects on cardiac uric acid and PAI-1 but not GSK-3: Improved safety profiles in contraception?","name":"articletitle","label":"Article Title"},{"value":"Pathophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathophys.2019.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}